Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2017

25.04.2017 | Epidemiology

Metabolic factors, anthropometric measures, diet, and physical activity in long-term breast cancer survivors: change from diagnosis and comparison to non-breast cancer controls

verfasst von: Ana Elisa Lohmann, Marguerite Ennis, Sara K. Taylor, Pamela J. Goodwin

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We studied metabolic factors, diabetes, and anthropometric measurements at diagnosis and long-term follow-up (LTFU), mean 12.5 years post-diagnosis, in breast cancer (BC) survivors, and compared their status at LTFU to that of age-matched women without BC. Diet and physical activity were also assessed.

Method

535 non-diabetic BC patients treated at three University of Toronto hospitals were followed prospectively; 285 surviving patients, without distant recurrence, participated in a LTFU study. A control group of 167 age-matched women without BC was recruited from a mammogram screening program at one of the hospitals. Change over time was analyzed using paired t tests, and comparisons between BC survivors and controls used age and education (AE)-adjusted regression models.

Results

Median weight gain in BC survivors was 2.00 kg (p < 0.0001); BMI, glucose, insulin, homeostasis model assessment (HOMA), and total cholesterol increased modestly but significantly. Waist circumference, glucose, and triglycerides were higher in LTFU BC survivors versus controls. BC survivors had significantly greater prevalence of diabetes/pre-diabetes versus controls (33 vs. 20.4%, AE-adjusted odds ratio (OR) 1.59, p = 0.050). This effect was restricted to those with lower levels of physical activity (<56 metabolic equivalent (MET)-hours/week: OR 2.70 versus 0.94 for those with higher physical activity, interaction p = 0.034). At LTFU, BC survivors were more physically active than at diagnosis (median increase 28 MET-hours/week interquartile range −14.8 to 82), and compared to controls (median 68.2 vs. 44 MET-hours/week, p < 0.0001).

Conclusion

The prevalence of the metabolic syndrome and diabetes/pre-diabetes was significantly higher in BC survivors than in controls group, notably in those with lower levels of physical activity. Enhanced diabetes/metabolic syndrome screening and promotion of physical activity may be warranted in BC survivors.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat NCD Risk Factor Collaboration (NCD-RisC) (2016) Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 387:1377–1396CrossRef NCD Risk Factor Collaboration (NCD-RisC) (2016) Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 387:1377–1396CrossRef
2.
Zurück zum Zitat Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120:1640–1645CrossRefPubMed Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120:1640–1645CrossRefPubMed
3.
Zurück zum Zitat Chan DS, Vieira AR, Aune D et al (2014) Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol 25:1901–1914CrossRefPubMedPubMedCentral Chan DS, Vieira AR, Aune D et al (2014) Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol 25:1901–1914CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Dobbins M, Decorby K, Choi BC (2013) The association between obesity and cancer risk: a meta-analysis of observational studies from 1985 to 2011. ISRN Prev Med 2013:680536CrossRefPubMedPubMedCentral Dobbins M, Decorby K, Choi BC (2013) The association between obesity and cancer risk: a meta-analysis of observational studies from 1985 to 2011. ISRN Prev Med 2013:680536CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Goodwin PJ, Ennis M, Pritchard KI et al (2012) Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol 30:164–171CrossRefPubMed Goodwin PJ, Ennis M, Pritchard KI et al (2012) Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol 30:164–171CrossRefPubMed
6.
Zurück zum Zitat Bhandari R, Kelley GA, Hartley TA et al (2014) Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis. Int J Breast Cancer 2014:189384CrossRefPubMedPubMedCentral Bhandari R, Kelley GA, Hartley TA et al (2014) Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis. Int J Breast Cancer 2014:189384CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Bjorge T, Lukanova A, Jonsson H et al (2010) Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 19:1737–1745CrossRefPubMed Bjorge T, Lukanova A, Jonsson H et al (2010) Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 19:1737–1745CrossRefPubMed
8.
Zurück zum Zitat National Institutes of Health (1982) Manual of laboratory operations, lipid research clinics program: lipid and lipoprotein analysis. National Institutes of Health, Bethesda National Institutes of Health (1982) Manual of laboratory operations, lipid research clinics program: lipid and lipoprotein analysis. National Institutes of Health, Bethesda
9.
Zurück zum Zitat Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed
10.
Zurück zum Zitat Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42–51CrossRefPubMed Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42–51CrossRefPubMed
11.
Zurück zum Zitat Farquhar JW, Fortmann SP, Maccoby N et al (1985) The stanford five-city project: design and methods. Am J Epidemiol 122:323–334CrossRefPubMed Farquhar JW, Fortmann SP, Maccoby N et al (1985) The stanford five-city project: design and methods. Am J Epidemiol 122:323–334CrossRefPubMed
12.
Zurück zum Zitat Sallis JF, Haskell WL, Wood PD et al (1985) Physical activity assessment methodology in the five-city project. Am J Epidemiol 121:91–106CrossRefPubMed Sallis JF, Haskell WL, Wood PD et al (1985) Physical activity assessment methodology in the five-city project. Am J Epidemiol 121:91–106CrossRefPubMed
13.
Zurück zum Zitat Bonora E, Targher G, Alberiche M et al (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57–63CrossRefPubMed Bonora E, Targher G, Alberiche M et al (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57–63CrossRefPubMed
14.
Zurück zum Zitat Program National Cholesterol Education (2002) (NCEP) Expert Panel on Detection, Evaluation: third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106:3143–3421 Program National Cholesterol Education (2002) (NCEP) Expert Panel on Detection, Evaluation: third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106:3143–3421
15.
Zurück zum Zitat Professional Practice Committee for the Standards of Medical Care in Diabetes-2016. Diabetes Care 39(Suppl 1):107 Professional Practice Committee for the Standards of Medical Care in Diabetes-2016. Diabetes Care 39(Suppl 1):107
16.
Zurück zum Zitat Lauzier S, Maunsell E, Drolet M et al (2008) Wage losses in the year after breast cancer: extent and determinants among Canadian women. J Natl Cancer Inst 100:321–332CrossRefPubMed Lauzier S, Maunsell E, Drolet M et al (2008) Wage losses in the year after breast cancer: extent and determinants among Canadian women. J Natl Cancer Inst 100:321–332CrossRefPubMed
17.
Zurück zum Zitat Lipscombe LL, Chan WW, Yun L et al (2013) Incidence of diabetes among postmenopausal breast cancer survivors. Diabetologia 56:476–483CrossRefPubMed Lipscombe LL, Chan WW, Yun L et al (2013) Incidence of diabetes among postmenopausal breast cancer survivors. Diabetologia 56:476–483CrossRefPubMed
18.
Zurück zum Zitat Bordeleau L, Lipscombe L, Lubinski J et al (2011) Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations. Cancer 117:1812–1818CrossRefPubMed Bordeleau L, Lipscombe L, Lubinski J et al (2011) Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations. Cancer 117:1812–1818CrossRefPubMed
19.
Zurück zum Zitat Lipscombe LL, Fischer HD, Yun L et al (2012) Association between tamoxifen treatment and diabetes: a population-based study. Cancer 118:2615–2622CrossRefPubMed Lipscombe LL, Fischer HD, Yun L et al (2012) Association between tamoxifen treatment and diabetes: a population-based study. Cancer 118:2615–2622CrossRefPubMed
20.
Zurück zum Zitat Hickish T, Astras G, Thomas P et al (2009) Glucose intolerance during adjuvant chemotherapy for breast cancer. J Natl Cancer Inst 101:537CrossRefPubMed Hickish T, Astras G, Thomas P et al (2009) Glucose intolerance during adjuvant chemotherapy for breast cancer. J Natl Cancer Inst 101:537CrossRefPubMed
21.
Zurück zum Zitat Dieli-Conwright CM, Wong L, Waliany S et al (2016) An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy. Cancer 22(17):2646–2653CrossRef Dieli-Conwright CM, Wong L, Waliany S et al (2016) An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy. Cancer 22(17):2646–2653CrossRef
Metadaten
Titel
Metabolic factors, anthropometric measures, diet, and physical activity in long-term breast cancer survivors: change from diagnosis and comparison to non-breast cancer controls
verfasst von
Ana Elisa Lohmann
Marguerite Ennis
Sara K. Taylor
Pamela J. Goodwin
Publikationsdatum
25.04.2017
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2017
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4263-z

Weitere Artikel der Ausgabe 2/2017

Breast Cancer Research and Treatment 2/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.